Cipla clarified that its supply partner Pharmathen received nine USFDA Form 483 observations during a November 2025 inspection of its Greece facility for Lanreotide Injection, and the company is ...
Freedom of Information Act requests filed with the Food and Drug Administration by hedge funds last month revealed big financial players closely eyeing warning letters, enforcement documents, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback